Article
FAT1: a potential target for monoclonal antibody therapy in colon cancer.
British journal of cancer - 28 Jun 2016
Pileri Piero, Campagnoli Susanna, Grandi Alberto, Parri Matteo, De Camilli Elisa, Song Chaojun, Ganfini Luisa, Lacombe Aurelien, Naldi Ilaria, Sarmientos Paolo, Cinti Caterina, Jin Boquan, Grandi Guido, Viale Giuseppe, Terracciano Luigi, Grifantini Renata
Abstract excerpt
BACKGROUND: Colorectal cancer (CRC) is one of the major causes of cancer-associated mortality worldwide. The currently approved therapeutic agents have limited efficacy. METHODS: The atypical cadherin FAT1 was discovered as a novel CRC-associated protein by using a monoclonal antibody (mAb198.3). FAT1 expression was assessed in CRC cells by immunohistochemistry (IHC), immunoblots, flow cytometry and confocal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
